Clene (CLNN) Net Shares Issued and Repurchased (2019 - 2025)
Clene (CLNN) posted Net Shares Issued and Repurchased of $903743.0 for Q4 2025, up 184.68% on a QoQ basis from $317455.0 in Q1 2025, and down 7.37% year-over-year from $975671.0 in Q4 2024.
Analysis
Clene (CLNN) Net Shares Issued and Repurchased (2019 - 2025) Analysis & Trends
Clene has reported Net Shares Issued and Repurchased for 7 years, with the latest figure at $903743.0 in Q4 2025.
- On a quarterly basis, Net Shares Issued and Repurchased fell 7.37% year-over-year to $903743.0 in Q4 2025; TTM through Dec 2025 was $903743.0, a 7.37% decrease from a year earlier, with the FY2025 full-year figure at $903743.0, down 7.37% from the prior year.
- Net Shares Issued and Repurchased was $903743.0 for Q4 2025 at Clene, up from $317455.0 in the prior quarter.
- The five-year high for Net Shares Issued and Repurchased was $7.1 million in Q4 2023, with the low at $280070.0 in Q1 2024.
- Average Net Shares Issued and Repurchased over 5 years is $2.5 million, with a median of $1.4 million recorded in 2021.
- The sharpest annual moves came in 2021 and 2024: Net Shares Issued and Repurchased jumped 1334.5% in 2021, then tumbled 86.17% in 2024.
- Over 5 years, Net Shares Issued and Repurchased stood at $3.9 million in 2021, then surged by 64.17% to $6.4 million in 2022, then increased by 10.7% to $7.1 million in 2023, then plunged by 86.17% to $975671.0 in 2024, then declined by 7.37% to $903743.0 in 2025.
- The last three Net Shares Issued and Repurchased figures came in at $903743.0 (Q4 2025), $317455.0 (Q1 2025), and $975671.0 (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | - |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | - |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | -3.07 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | - |
| 10 | Clene | 45.69 Mn | 45.69 Mn | 54,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 903,743.00 |
| Mar 31, 2025 | 317,455.00 |
| Dec 31, 2024 | 975,671.00 |
| Mar 31, 2024 | 280,070.00 |
| Dec 31, 2023 | 7.05 Mn |
| Mar 31, 2023 | 1.08 Mn |
| Dec 31, 2022 | 6.37 Mn |
| Mar 31, 2022 | 2.49 Mn |
| Dec 31, 2021 | 3.88 Mn |
| Mar 31, 2021 | 1.63 Mn |
| Dec 31, 2020 | 270,555.00 |
| Dec 31, 2019 | 1.44 Mn |